← Back to Search

Local Anesthetic

Nerve Block for Pain Management

Phase < 1
Recruiting
Led By Morgan Ritz, MD
Research Sponsored by The University of Texas Health Science Center at San Antonio
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to study procedure end (approximately 30 minutes)
Awards & highlights

Study Summary

This trial will use a nerve block to help with pain relief and reduce need for opiates in patients with rib fractures, vertebral fractures, pancreatitis, etc.

Who is the study for?
This trial is for adults with certain painful conditions like rib or vertebral fractures, pancreatitis, pancreatic cancer, renal colic, and back pain. It's not suitable for those with unstable vital signs, skin infections at the injection site, allergies to local anesthetics, pregnant women or individuals under 18.Check my eligibility
What is being tested?
The study tests if injecting Bupivacaine into the erector spinae muscles can help manage pain from specific conditions and reduce the need for opioid painkillers after treatment.See study design
What are the potential side effects?
Possible side effects of Bupivacaine include numbness in treated areas, weakness in legs if used on back pain patients, low blood pressure, nausea or vomiting. Rarely it may cause severe allergic reactions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to study procedure end (approximately 30 minutes)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to study procedure end (approximately 30 minutes) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Pain Scale Rating

Trial Design

1Treatment groups
Experimental Treatment
Group I: Erector Spinae Plane Block (ESP) administrationExperimental Treatment1 Intervention
Patients with the listed diagnoses will be offered and then consented for an ESPB under ultrasound guidance.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Bupivacaine Injection
2017
Completed Phase 4
~580

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center at San AntonioLead Sponsor
453 Previous Clinical Trials
91,940 Total Patients Enrolled
Morgan Ritz, MDPrincipal InvestigatorUniversity of Texas Health Science Center San Antonio

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there remaining vacancies for enrollees in this trial?

"Affirmative. Clinicaltrials.gov reveals that the study, which was initially posted on September 15th 2023, is recruiting participants at present. Its most recent update occurred on October 17th 2023."

Answered by AI

What is the total number of individuals participating in this research?

"Affirmative. Based on the information available from clinicaltrials.gov, this medical research is currently searching for 40 participants to be recruited from a single location. The trial was first advertised on September 15th 2023 and had its most recent update on October 17th of last year."

Answered by AI

Who else is applying?

What site did they apply to?
Crozer Chester Medical Center
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Erector Spinae Regional Anesthesia for Pain Control
2023. "Erector Spinae Regional Anesthesia for Pain Control". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05794828.
~25 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top